7.13
price up icon0.00%   0.00
after-market Handel nachbörslich: 7.14 0.010 +0.14%
loading

Finanzdaten der Tempest Therapeutics Inc-Aktie (TPST)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Interest Income/Expense
2.39%
0.368
0.377 0.373 0.355 0.344
Operating Income/Loss
6.12%
-7.974
-7.514 -6.592 -7.47 -7.581
Nonoperating Income/Loss
169.23%
0.07
0.026 -0.194 -0.111 -0.055
Income/Loss From Continuing Operations Before Tax
5.56%
-7.904
-7.488 -6.786 -7.581 -7.636
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
5.56%
-7.904
-7.488 -6.786 -7.581 -7.636
Net Income/Loss
5.56%
-7.904
-7.488 -6.786 -7.581 -7.636
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,538%
22.23
1.3572 14.12 14.10 13.76
Diluted Average Shares
1,538%
22.23
1.3572 14.12 14.10 13.76
Basic Earnings Per Share
5.88%
-0.36
-0.34 -0.48 -0.54 -0.55
Diluted Earnings Per Share
5.88%
-0.36
-0.34 -0.48 -0.54 -0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Kapitalisierung:     |  Volumen (24h):